Climb Bio Net Debt Growth & History (CLYM)
Climb Bio's net debt was −$35.1M for fiscal 2025.
View full Climb Bio company overviewClimb Bio annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$35.1M | $51.6M | — |
| 2024 | 2024-12-31 | −$86.7M | $6.1M | — |
| 2023 | 2023-12-31 | −$92.8M | −$49.7M | — |
| 2022 | 2022-12-31 | −$43.1M | $3.8M | — |
| 2021 | 2021-12-31 | −$46.9M | — | — |
Climb Bio quarterly net debt
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$42.8M | −$20.8M | — |
| Q1 2026 | 2026-03-31 | −$7.9M | $20.7M | — |
| Q4 2025 | 2025-12-31 | −$35.1M | $51.6M | — |
| Q3 2025 | 2025-09-30 | −$25.2M | $120.9M | — |
| Q2 2025 | 2025-06-30 | −$22.0M | $201.0M | — |
| Q1 2025 | 2025-03-31 | −$28.5M | $76.3M | — |
| Q4 2024 | 2024-12-31 | −$86.7M | $6.1M | — |
| Q3 2024 | 2024-09-30 | −$146.1M | −$89.2M | — |
| Q2 2024 | 2024-06-30 | −$223.0M | −$198.3M | — |
| Q1 2024 | 2024-03-31 | −$104.8M | −$71.1M | — |
| Q4 2023 | 2023-12-31 | −$92.8M | −$49.7M | — |
| Q3 2023 | 2023-09-30 | −$56.9M | −$21.5M | — |
| Q2 2023 | 2023-06-30 | −$24.7M | $7.2M | — |
| Q1 2023 | 2023-03-31 | −$33.8M | −$2.7M | — |
| Q4 2022 | 2022-12-31 | −$43.1M | $3.8M | — |
| Q3 2022 | 2022-09-30 | −$35.4M | — | — |
| Q2 2022 | 2022-06-30 | −$31.9M | — | — |
| Q1 2022 | 2022-03-31 | −$31.1M | — | — |
| Q4 2021 | 2021-12-31 | −$46.9M | — | — |
Climb Bio net debt trends
Between the periods ended 2021-12-31 and 2025-12-31, Climb Bio's net debt increased from −$46.9M to −$35.1M, a change of $11.8M. The latest reported quarter, Q2 2026, shows −$42.8M.
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Climb Bio source filings ↗